“The opportunity is the chance to make a difference by translating findings in the booming field of aging research directly to consumers today.”
25+ Internationally Renowned
Institutional Partnerships Include
Oxford and Yale
10 Ongoing and Completed
Human Clinical Trials
NSF for Sport Certification and 3rd-Party
Tested for Purity and Quality
Customer Support from Real People
Awarded the First Seal for Innovation
from Good Housekeeping
Leonard Guarente, Ph.D.
Basis – Cellular Aging
Director of The Paul F. Glenn Center for Biology of Aging Research at MIT
Leonard Guarente, Ph.D., is a founder of Elysium and the company’s chief scientist, a role in which he directs research and product development. Since 2008 he has led the Glenn Center for Biology of Aging Research at MIT, where his research has focused on the genetic and molecular basis of aging. He is the Novartis Professor of Biology at MIT.
A. David Smith, Ph.D.
Matter – Cognitive Aging
Professor Emeritus of Pharmacology and Founding Director of Oxford Project to Investigate Memory and Ageing (OPTIMA)
A. David Smith, Ph.D., is a Scientific Advisory Board member of Elysium and the lead researcher behind our brain health product Matter. Smith has spent his entire career at the University of Oxford, where he investigated the role of micronutrients, especially B vitamins, in relation to the functioning of the brain and prevention of cognitive decline. As part of this research, Smith co-founded OPTIMA, which pioneered the study of the prevention of cognitive decline by identifying modifiable risk factors.
Morgan Levine, Ph.D.
Index - Rate of Aging
Yale School of Medicine, Assistant Professor of Pathology and Epidemiology
Morgan Levine, Ph.D., is bioinformatics advisor of Elysium Health, where she led the development of Index by Elysium Health using the next-generation technology Algorithmic Platform for Epigenetic Examination (APEX). Levine is a Yale School of Medicine assistant professor and aging researcher in the Department of Pathology and a member of the Yale Combined Program in Computational Biology and Bioinformatics as well as the Yale Center for Research on Aging.
“A renowned MIT aging scientist as cofounder. Not one, not two, but [eight] Nobel prize laureates as scientific advisors. It’s no wonder the dietary supplement company Elysium has attracted attention in an industry not exactly known for scientific rigor.”
"Most impressively, the company’s co-founder is Leonard Guarente, who heads MIT’s aging center and is one of the pioneers of aging science, a contender for the Nobel Prize should geroscience ever get a nod from the Swedish academy.”
“Elysium collaborates with world-renowned international academic institutions to maintain the highest standards of practice, and their thought leadership is helping change the conversation in preventive health and wellness.”
NAD+ is essential to the creation of energy in the body and the regulation of pivotal cellular processes. Here’s why it’s so important, how it was discovered, and how you can get more of it.
NR is often thought of as a highly efficient precursor to NAD+, but its cousin molecule NMN, while not an ingredient in Basis, is raising eyebrows as the new kid on the block.
These two forms of nicotinamide adenine dinucleotide are not exactly the same thing, but they’re chemically similar. It’s complicated. We’ll explain.
This potent polyphenol is promising in scientific research because of its molecular structure and bioavailability. But it might be able to do more than we even know.